Global prevalence of dementia: a Delphi consensus study
- PMID: 16360788
- PMCID: PMC2850264
- DOI: 10.1016/S0140-6736(05)67889-0
Global prevalence of dementia: a Delphi consensus study
Abstract
Background: 100 years after the first description, Alzheimer's disease is one of the most disabling and burdensome health conditions worldwide. We used the Delphi consensus method to determine dementia prevalence for each world region.
Methods: 12 international experts were provided with a systematic review of published studies on dementia and were asked to provide prevalence estimates for every WHO world region, for men and women combined, in 5-year age bands from 60 to 84 years, and for those aged 85 years and older. UN population estimates and projections were used to estimate numbers of people with dementia in 2001, 2020, and 2040. We estimated incidence rates from prevalence, remission, and mortality.
Findings: Evidence from well-planned, representative epidemiological surveys is scarce in many regions. We estimate that 24.3 million people have dementia today, with 4.6 million new cases of dementia every year (one new case every 7 seconds). The number of people affected will double every 20 years to 81.1 million by 2040. Most people with dementia live in developing countries (60% in 2001, rising to 71% by 2040). Rates of increase are not uniform; numbers in developed countries are forecast to increase by 100% between 2001 and 2040, but by more than 300% in India, China, and their south Asian and western Pacific neighbours.
Interpretation: We believe that the detailed estimates in this paper constitute the best currently available basis for policymaking, planning, and allocation of health and welfare resources.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Estimating the number of people living with dementia at different stages of the condition in India: A Delphi process.Dementia (London). 2024 Apr;23(3):438-451. doi: 10.1177/14713012231181627. Epub 2023 Jun 5. Dementia (London). 2024. PMID: 37272749 Free PMC article.
-
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol. 2019 Jan;18(1):88-106. doi: 10.1016/S1474-4422(18)30403-4. Epub 2018 Nov 26. Lancet Neurol. 2019. PMID: 30497964 Free PMC article.
-
Mapping the Numbers of Dementia in Brazil: A Delphi Consensus Study.Int J Geriatr Psychiatry. 2025 Feb;40(2):e70055. doi: 10.1002/gps.70055. Int J Geriatr Psychiatry. 2025. PMID: 39938925
-
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4. Lancet Glob Health. 2019. PMID: 31303293
Cited by
-
Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.Curr Opin Neurol. 2012 Apr;25(2):125-30. doi: 10.1097/WCO.0b013e3283518226. Curr Opin Neurol. 2012. PMID: 22357218 Free PMC article. Review.
-
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.BMC Neurol. 2015 Apr 28;15:66. doi: 10.1186/s12883-015-0325-1. BMC Neurol. 2015. PMID: 25927641 Free PMC article.
-
Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.J Nutr Health Aging. 2013 Apr;17(4):378-84. doi: 10.1007/s12603-012-0397-1. J Nutr Health Aging. 2013. PMID: 23538662
-
What should we know about dementia in the 21st century? A Delphi consensus study.BMC Geriatr. 2015 Feb 6;15:5. doi: 10.1186/s12877-015-0008-1. BMC Geriatr. 2015. PMID: 25656075 Free PMC article.
-
Pathological Defects in a Drosophila Model of Alzheimer's Disease and Beneficial Effects of the Natural Product Lisosan G.Biomolecules. 2024 Jul 15;14(7):855. doi: 10.3390/biom14070855. Biomolecules. 2024. PMID: 39062569 Free PMC article.
References
-
- World Health Organization . World Health Report 2003—Shaping the future. WHO; Geneva: 2003.
-
- Comas-Herrera A, Wittenberg R, Pickard L, Knapp M, MRC-CFAS . PSSRU Discussion Paper. 2005. Cognitive impairment in older people: its implications for future demand for services and costs; p. 1728. - PubMed
-
- Schneider J, Murray J, Banerjee S, Mann A. EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—factors associated with carer burden. Int J Geriatr Psychiatry. 1999;14:651–61. - PubMed
-
- 10/66 Dementia Research Group Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry. 2004;19:170–77. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical